-
1 Comment
Hainan Poly Pharm. Co., Ltd is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 120.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.2.
Hainan Poly Pharm. Co., Ltd's total revenue rose by 48.2% to $380M since the same quarter in the previous year.
Its net income has increased by 47.1% to $126M since the same quarter in the previous year.
Finally, its free cash flow fell by 83.3% to $-65M since the same quarter in the previous year.
Based on the above factors, Hainan Poly Pharm. Co., Ltd gets an overall score of 3/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Sector | Healthcare |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100002N10 |
| Market Cap | 488M |
|---|---|
| PE Ratio | None |
| Target Price | 48.99 |
| Beta | 0.18 |
| Dividend Yield | None |
Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company's dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, excipients, prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was founded in 1992 and is headquartered in Haikou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300630.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
